Publication

Mimicking Phosphorylation at Serine 87 Inhibits the Aggregation of Human α-Synuclein and Protects against Its Toxicity in a Rat Model of Parkinson's Disease

Publications associées (56)

À propos
Confidentialité
Mentions légales

Graph Chatbot

Chattez avec Graph Search

Posez n’importe quelle question sur les cours, conférences, exercices, recherches, actualités, etc. de l’EPFL ou essayez les exemples de questions ci-dessous.

AVERTISSEMENT : Le chatbot Graph n'est pas programmé pour fournir des réponses explicites ou catégoriques à vos questions. Il transforme plutôt vos questions en demandes API qui sont distribuées aux différents services informatiques officiellement administrés par l'EPFL. Son but est uniquement de collecter et de recommander des références pertinentes à des contenus que vous pouvez explorer pour vous aider à répondre à vos questions.

Connectez-vous pour utiliser Chat avec Graph Search

Mimicking Phosphorylation at Serine 87 Inhibits the Aggregation of Human α-Synuclein and Protects against Its Toxicity in a Rat Model of Parkinson's Disease

Graph Chatbot

Chattez avec Graph Search

Direct and Retrograde Transduction of Nigral Neurons with AAV6, 8, and 9 and Intraneuronal Persistence of Viral Particles

The many faces of α-synuclein: from structure and toxicity to therapeutic target

Use of viral vectors to create animal models for Parkinson's disease

Use of viral vectors to create animal models for Parkinson's disease

Role of the FoxO3a Transcription Factor in alpha-synuclein Induced Neurodegeneration

PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity

Neurodegenerative phenotypes in an A53T-synuclein transgenic mouse model are independent of LRRK2

Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease

Alpha-Synuclein Effects at the ER-to-Golgi Level and Potential Biomarkers in Rat Models of the Early Phase of Parkinson's Disease

Rab1A Over-Expression Prevents Golgi Apparatus Fragmentation and Partially Corrects Motor Deficits in an Alpha-Synuclein Based Rat Model of Parkinson’s Disease

Alpha-Synuclein Effects at the ER-to-Golgi Level and Potential Biomarkers in Rat Models of the Early Phase of Parkinson's Disease

Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease

Neurodegenerative phenotypes in an A53T-synuclein transgenic mouse model are independent of LRRK2

Direct and Retrograde Transduction of Nigral Neurons with AAV6, 8, and 9 and Intraneuronal Persistence of Viral Particles

Use of viral vectors to create animal models for Parkinson's disease

Use of viral vectors to create animal models for Parkinson's disease

The many faces of α-synuclein: from structure and toxicity to therapeutic target

Role of the FoxO3a Transcription Factor in alpha-synuclein Induced Neurodegeneration

Rab1A Over-Expression Prevents Golgi Apparatus Fragmentation and Partially Corrects Motor Deficits in an Alpha-Synuclein Based Rat Model of Parkinson’s Disease

PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity